Interleukin-2R antagonists in the prevention of acute rejection in living donor transplantation

Transplantation Proceedings

Volumn 33, Issue 7-8, 2001, Pages 3203-3204

  Ivanovski, N ^a,b   Popov, Z ^a   Kolevski, P ^a   Cakalaroski, K ^a   Spasovski, G ^a   Sikole, A ^a   Paneva Masin, J ^a  

^a Departments of Nephrology   (Macedonia)

^b University Clinical Center Skopje   (Macedonia)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; CYCLOSPORIN A; INTERLEUKIN 2 RECEPTOR ANTIBODY; LYMPHOCYTE ANTIBODY; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; OKT 3; PREDNISOLONE;

AGE; ARTICLE; CAUSE OF DEATH; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; DRUG EFFICACY; GRAFT SURVIVAL; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY BIOPSY; KIDNEY DONOR; KIDNEY GRAFT REJECTION; LIVING DONOR; PRIORITY JOURNAL; RECIPIENT; SURVIVAL RATE; TREATMENT OUTCOME;

ANTIBODIES, MONOCLONAL; AZATHIOPRINE; CYCLOSPORINE; DRUG RESISTANCE; DRUG THERAPY, COMBINATION; FOLLOW-UP STUDIES; GRAFT REJECTION; HUMANS; IMMUNOGLOBULIN G; IMMUNOSUPPRESSIVE AGENTS; KIDNEY TRANSPLANTATION; LIVING DONORS; MYCOPHENOLIC ACID; RECEPTORS, INTERLEUKIN-2; RECOMBINANT FUSION PROTEINS; RETROSPECTIVE STUDIES; STEROIDS; TIME FACTORS;

EID: 0035671843     PISSN: 00411345     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0041-1345(01)02363-6     Document Type: Article

References (6)

1. Madden RL, Mulhern JG, Benedetto BJ, et al: Transpl Int 13:344, 2000
2. Almond PS, Matas A, Gillingham K, et al: Transplantation 55:752, 1993
3. Ivanovski N, Popov Z, Kolevski P, et al: Clin Nephrol 55:309, 2001
4. Ekberg H, Backman L, Tufveson G, et al: Transpl Int 13:151, 2000
5. Jin DC, Yoon YS, Kim Ys, et al: Clin Transplant 10:471, 1996.
6. Shidban H, Sabawi M, Aswad S, et al: Transplantation 69:5156, 2000